Vascular endothelial growth factor receptor-1 in human cancer: concise review and rationale for development of IMC-18F1 (Human antibody targeting vascular endothelial growth factor receptor-1).
第一作者:
Jonathan D,Schwartz
第一单位:
ImClone Systems Corporation, 33 ImClone Drive, Branchburg, NJ 08876, USA. jonathan.schwartz@imclone.com
作者:
主题词
动物(Animals);抗体, 单克隆(Antibodies, Monoclonal);抗肿瘤药(Antineoplastic Agents);细胞系, 肿瘤(Cell Line, Tumor);药物释放系统(Drug Delivery Systems);造血干细胞(Hematopoietic Stem Cells);人类(Humans);炎症(Inflammation);配体(Ligands);模型, 生物学(Models, Biological);肿瘤转移(Neoplasm Metastasis);肿瘤(Neoplasms);新生血管化, 生理性(Neovascularization, Physiologic);血管内皮生长因子受体1(Vascular Endothelial Growth Factor Receptor-1)
DOI
10.1002/cncr.24789
PMID
20127948
发布时间
2010-02-10
- 浏览92

Cancer
1027-32页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文